Roche announces phase II clinical results of crenezumab in Alzheimer’s disease
Roche presented data from two phase II studies investigating whether…
17 July 2014 | By Roche
Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease...